A Study of DXC006 in Patients With Advanced Solid Tumors and Hematologic Malignancies
Clinical trial NCT06224855 · RECRUITING
Trial details
- NCT number
- NCT06224855
- Sponsor
- Hangzhou DAC Biotechnology Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-24
- Primary completion
- 2027-06-30
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.